Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07120464Recruiting

Clinical Study on Immunogenicity and Safety of Lyophilized Vero Cell-Derived Human Rabies Vaccine in Special Populations

Role: collaborator

NCT05622513Completed

Phthalate Esters and Childhood Obesity

Role: lead

NCT03345927Completed

Plasma S-adenosylhomocysteine Levels and Endothelial Dysfunction

Role: lead

NCT04317014Completed

the Association Between Obesity and Early Puberty

Role: lead

NCT04012632Completed

Kisspeptin/GPR54 Pathway and Early Puberty

Role: lead

All 5 trials loaded